Metabolic syndrome is associated with insulin resistance, elevated glucose and lipids, inflammation, decreased antioxidant activity, increased weight gain, and increased glycation of proteins. Cinnamon has been shown to improve all of these variables in in vitro, animal, and/or human studies. In addition, cinnamon has been shown to alleviate factors associated with Alzheimer's disease by blocking and reversing tau formation in vitro and in ischemic stroke by blocking cell swelling. In vitro studies also show that components of cinnamon control angiogenesis associated with the proliferation of cancer cells. Human studies involving control subjects and subjects with metabolic syndrome, type 2 diabetes mellitus, and polycystic ovary syndrome all show beneficial effects of whole cinnamon and/or aqueous extracts of cinnamon on glucose, insulin, insulin sensitivity, lipids, antioxidant status, blood pressure, lean body mass, and gastric emptying. However, not all studies have shown positive effects of cinnamon, and type and amount of cinnamon, as well as the type of subjects and drugs subjects are taking, are likely to affect the response to cinnamon. In summary, components of cinnamon may be important in the alleviation and prevention of the signs and symptoms of metabolic syndrome, type 2 diabetes, and cardiovascular and related diseases.
DugouaJJSeelyDPerriDCooleyKForelliTMillsEKorenG. From type 2 diabetes to antioxidant activity: A systematic review of the safety and efficacy of common and cassia cinnamon bark. Can J Physiol Pharmacol.2007;85 (9): 837–47.
2.
AndersonRARousselAM. Cinnamon, glucose and insulin sensitivity. In: PasupuletiVAndersonJW, editors. Nutraceuticals, glycemic health and type 2 diabetes. IFT Press Series, Wiley-Blackwell Publishing; 2008. p. 127–40.
3.
PanickarKSCaoHQinBAndersonRA. Molecular targets and health benefits of cinnamon. In: AggarwalBBKunnumakkaraAB, editors. Molecular targets and therapeutic uses of spices. Hackensack, NJ: World Scientific Publishing Co.; 2009. p. 87–116.
4.
KhanABrydenNAPolanskyMMAndersonRA. Insulin potentiating factor and chromium content of selected foods and spices. Biol Trace Elem Res.1990;24 (3): 183–8.
5.
BroadhurstCLPolanskyMMAndersonRA. Insulin-like biological activity of culinary and medicinal plant aqueous extracts in vitro. J Agric Food Chem.2000;48 (3): 849–52.
6.
AndersonRABroadhurstCLPolanskyMMSchmidtWFKhanAFlanaganVPSchoeneNWGravesDJ. Isolation and characterization of polyphenol type-A polymers from cinnamon with insulin-like biological activity. J Agric Food Chem.2004;52 (1): 65–70.
7.
Jarvill-TaylorKJAndersonRAGravesDJ. A hydroxychalcone derived from cinnamon functions as a mimetic for insulin in 3T3-L1 adipocytes. J Am Coll Nutr.2001;20 (4): 327–36.
8.
CaoHPolanskyMMAndersonRA. Cinnamon extract and polyphenols affect the expression of tristetraprolin, insulin receptor, and glucose transporter 4 in mouse 3T3-L1 adipocytes. Arch Biochem Biophys.2007;459 (2): 214–22.
9.
PetersonDWGeorgeRCScaramozzinoFLaPointeNEAndersonRAGravesDJLewJ. Cinnamon extract inhibits tau aggregation associated with Alzheimer's disease in vitro. J Alzheimers Dis.2009;17 (3): 585–7.
10.
LuJZhangKNamSAndersonRAJoveRWenW. Novel angiogenesis inhibitory activity in cinnamon extract blocks VEGFR2 kinase and downstream signaling. Carcinogenesis.2010;31 (3): 481–8.
11.
QinBNagasakiMRenMBajottoGOshidaYSatoY. Cinnamon extract (traditional herb) potentiates in vivo insulin-regulated glucose utilization via enhancing insulin signaling in rats. Diabetes Res Clin Pract.2003;62 (3): 139–48.
12.
QinBNagasakiMRenMBajottoGOshidaYSatoY. Cinnamon extract prevents the insulin resistance induced by a high-fructose diet. Horm Metab Res.2004;36 (2): 119–25.
13.
WangJGAndersonRAGrahamGM3rdChuMCSauerMVGuarnacciaMMLoboRA. The effect of cinnamon extract on insulin resistance parameters in polycystic ovary syndrome: A pilot study. Fertil Steril.2007;88 (1): 240–3.
14.
QinBPolanskyMMAndersonRA. Cinnamon extract regulates plasma levels of adipose-derived factors and expression of multiple genes related to carbohydrate metabolism and lipogenesis in adipose tissue of fructose-fed rats. Horm Metab Res.2010;42 (3): 187–93.
15.
HandbergALevinKHojlundKBeck-NielsenH. Identification of the oxidized low-density lipoprotein scavenger receptor CD36 in plasma: A novel marker of insulin resistance. Circulation.2006;114 (11): 1169–76.
16.
YangYZhouLGuYZhangYTangJLiFShangWJiangBYueXChenM. Dietary chickpeas reverse visceral adiposity, dyslipidaemia and insulin resistance in rats induced by a chronic high-fat diet. Br J Nutr.2007;98 (4): 720–6.
17.
GrahamTEYangQBlüherMHammarstedtACiaraldiTPHenryRRWasonCJOberbachAJanssonPASmithUKahnBB. Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. N Engl J Med.2006;354 (24): 2552–63.
18.
PolonskyKS. Retinol-binding protein 4, insulin resistance, and type 2 diabetes. N Engl J Med.2006;354 (24): 2596–8.
19.
Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G; Atherosclerosis Risk in Communities Study. Low-grade systemic inflammation and the development of type 2 diabetes: The atherosclerosis risk in communities study. Diabetes.2003;52 (7): 1799–805.
20.
CaoHUrbanJFJrAndersonRA. Cinnamon polyphenol extract affects immune responses by regulating anti- and proinflammatory and glucose transporter gene expression in mouse macrophages. J Nutr.2008;138 (5): 833–40.
21.
BouchardLVohlMCDeshaiesYRheaumeCDarisMTchernofA. Visceral adipose tissue zinc finger protein 36 mRNA levels are correlated with insulin, insulin resistance index, and adiponectinemia in women. Eur J Endocrinol.2007;157 (4): 451–7.
22.
QinBQiuWAvramogluRKAdeliK. Tumor necrosis factor-alpha induces intestinal insulin resistance and stimulates the overproduction of intestinal apolipoprotein B48-containing lipoproteins. Diabetes.2007;56 (2): 450–61.
23.
QinBDawsonHDAndersonRA. Elevation of TNF-alpha induces the overproduction of postprandial intestinal apolipoprotein B-48-containing VLDL particles. Exp Biol Med. In press 2010.
24.
QinBDawsonHPolanskyMMAndersonRA. Cinnamon extract attenuates TNF-alpha-induced intestinal lipoprotein ApoB48 overproduction by regulating inflammatory, insulin, and lipoprotein pathways in enterocytes. Horm Metab Res.2009;41 (7): 516–22.
25.
PengXChengKWMaJChenBHoCTLoCChenFWangM. Cinnamon bark proanthocyanidins as reactive carbonyl scavengers to prevent the formation of advanced glycation endproducts. J Agric Food Chem.2008;56 (6): 1907–11.
NishimuraSManabeINagasakiMHosoyaYYamashitaHFujitaHOhsugiMTobeKKadowakiTNagaiRSugiuraS. Adipogenesis in obesity requires close interplay between differentiating adipocytes, stromal cells, and blood vessels. Diabetes.2007;56 (6): 1517–26.
28.
FerrariAHoerndliFBaechiTNitschRMGotzJ. Beta-Amyloid induces paired helical filament-like tau filaments in tissue culture. J Biol Chem.2003;278 (41): 40162–8.
29.
De la MonteSMWandsJR. Alzheimer's disease is type 3 diabetes-evidence reviewed. J Diabetes Sci Technol.2008;2 (6): 1101–13.
30.
Blurton-JonesMLaFerlaFM. Pathways by which Abeta facilitates tau pathology. Curr Alzheimer Res.2006;3 (5): 437–48.
31.
PanickarKSPolanskyMMAndersonRA. Cinnamon polyphenols attenuate cell swelling and mitochondrial dysfunction following oxygen-glucose deprivation in glial cells. Exp Neurol.2009;216 (2): 420–7.
32.
KhanASafdarMKhanMM AliKhattakKNAndersonRA. Cinnamon improves glucose and lipids of people with type 2 diabetes. Diabetes Care.2003;26 (12): 3215–8.
33.
SolomonTPBlanninAK. Effects of short-term cinnamon ingestion on in vivo glucose tolerance. Diabetes Obes Metab.2007;9 (6): 895–901.
34.
SolomonTPBlanninAK. Changes in glucose tolerance and insulin sensitivity following 2 weeks of daily cinnamon ingestion in healthy humans. Eur J Appl Physiol.2009;105 (6): 969–76.
35.
HlebowiczJDarwicheGBjorgellOAlmerLO. Effect of cinnamon on postprandial blood glucose, gastric emptying, and satiety in healthy subjects. Am J Clin Nutr.2007;85 (6): 1552–6.
36.
HlebowiczJHlebowiczALindstedtSBjörgellOHöglundPHolstJJDarwicheGAlmérLO. Effects of 1 and 3 g cinnamon on gastric emptying, satiety, and postprandial blood glucose, insulin, glucose-dependent insulinotropic polypeptide, glucagon-like peptide 1, and ghrelin concentrations in healthy subjects. Am J Clin Nutr.2009;89 (3): 815–21.
37.
TangMLarson-MeyerDELiebmanM. Effect of cinnamon and turmeric on urinary oxalate excretion, plasma lipids, and plasma glucose in healthy subjects. Am J Clin Nutr.2008;87 (5): 1262–7.
38.
ZiegenfussTNHofheinsJEMendelRWLandisJAndersonRA. Effects of a water-soluble cinnamon extract on body composition and features of the metabolic syndrome in pre-diabetic men and women. J Int Soc Sports Nutr.2006;3: 45–53.
39.
RousselAMHiningerIBenarabaRZiegenfussTNAndersonRA. Antioxidant effects of a cinnamon extract in people with impaired fasting glucose that are overweight or obese. J Am Coll Nutr.2009;28 (1): 16–21.
40.
YuYLyonsTJ. A lethal tetrad in diabetes: Hyperglycemia, dyslipidemia, oxidative stress, and endothelial dysfunction. Am J Med Sci.2005;330 (5): 227–32.
41.
HaydenMRTyagiSC. Neural redox stress and remodeling in metabolic syndrome, type 2 diabetes mellitus, and diabetic neuropathy. Med Sci Monit.2004;10 (12): RA291–307.
42.
MangBWoltersMSchmittBKelbKLichtinghagenRStichtenothDOHahnA. Effects of a cinnamon extract on plasma glucose, HbA, and serum lipids in diabetes mellitus type 2. Eur J Clin Invest.2006;36 (5): 340–4.
CrawfordP. Effectiveness of cinnamon for lowering hemoglobin A1C in patients with type 2 diabetes: A randomized, controlled trial. J Am Board Fam Med.2009;22 (5): 507–12.
45.
UK Prospective Diabetes Study (UKPDS) Group. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet.1998;352 (9131): 837–53.
46.
FairmanKACurtissFR. Call for comparative effectiveness research: Lowering a1c with sitagliptin, saxagliptin, or cinnamon. J Manag Care Pharm.2009;15 (8): 696–700.
47.
BlevinsSMLeyvaMJBrownJWrightJScofieldRHAstonCE. Effect of cinnamon on glucose and lipid levels in non insulin-dependent type 2 diabetes. Diabetes Care.2007;30 (9): 2236–7.
48.
SuppapitipornSKanpaksiNSuppapitipornS. The effect of cinnamon cassia powder in type 2 diabetes mellitus. J Med Assoc Thai.2006;89Suppl 3: S200–5.
49.
BakerWLGutierrez-WilliamsGWhiteCMKlugerJColemanCI. Effect of cinnamon on glucose control and lipid parameters. Diabetes Care.2008;31 (1): 41–3.
50.
AltschulerJACasellaSJMacKenzieTACurtisKM. The effect of cinnamon on A1C among adolescents with type 1 diabetes. Diabetes Care.2007;30 (4): 813–6.
51.
VanschoonbeekKThomassenBJSendenJMWodzigWKvan LoonLJ. Cinnamon supplementation does not improve glycemic control in postmenopausal type 2 diabetes patients. J Nutr.2006;136 (4): 977–80.
